Virtual-Integrated Twin for Autonomous Lifesaving (VITAL)

The DARPA VITAL (Virtual Integrated Twin for Autonomous Lifesaving) solicitation seeks abstracts—limited to seven written pages—that clearly articulate the offeror’s understanding of the program’s purpose, technical goals, and primary risks, as well as the proposer’s ability to execute the effort. The abstract must include a one‑page technical approach summary, a one‑page technical challenges and risk identification section, and a description of the team’s technical ability, past performance, and relevant qualifications; no copy‑and‑paste from the solicitation is permitted. Proposers must also define all deliverables (data, reports, software, etc.) for each base task and subtask, specify work locations (e.g., university campuses), and outline milestones. If the abstract is accepted, the offeror will be invited to submit an Oral Presentation Proposal (OPP) package and deliver a presentation that details innovative claims, risk mitigation plans, facilities, and any teaming or subcontractor contributions. The effort is a 36‑month, two‑phase Other Transaction (OT) prototype agreement, with a Phase 1 award and an option for Phase 2. Abstracts are due May 20 2026, 5:00 PM ET. The solicitation is open to all responsible sources—including large and small businesses, non‑traditional defense contractors, universities, and research institutions—and does not prescribe a specific team composition. Cost sharing is not required unless a traditional defense contractor partners significantly with a non‑traditional contractor. Evaluation will focus on the proposer’s grasp of VITAL’s challenges, the feasibility of the technical solution, and the robustness of risk mitigation strategies.

Notice ID

3e66d960c0a14d51b236bbcf712d34cf

Solicitation Number

DARPA-PS-26-26

NAICS Code

541714

Classification Code

AC12